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KESAN EKSTRAK DAN PECAHAN KULIT BAWANG MERAH (Allium cepa) 




Kanser merupakan punca utama kematian di Malaysia dan juga negara-
negara yang sedang membangun. Penyakit tersebut menyebabkan sel-sel tidak 
normal membahagi tanpa kawalan serta berupaya menyerang tisu normal. Walaupun 
terdapat perkembangan dalam rawatan kanser, kadar kematian kanser masih tinggi 
terutamanya pesakit kanser yang invasif. Oleh itu, penemuan anti-kanser ejen yang 
berkesan daripada semua sumber perlu dilakukan. Flavonoid, seperti quercetin, boleh 
didapati dalam kandungan yang tinggi dalam isi bawang dan juga kulit bawang. 
Flavonoid telah dibuktikan dapat menggalak aktiviti anti-proliferatif dan berpotensi 
anti-kanser. Oleh sebab itu, kajian ini dijalankan dengan objektif untuk mengkaji 
anti-kanser aktiviti ekstrak dan pecahan kulit bawang merah (Allium cepa) terhadap 
MDA-MB-231, MCF-7 dan Cal-27. Kesan ekstrak dan pecahan kulit bawang merah 
dalam aktiviti anti-proliferatif, induksi apoptosis-kematian sel diprogram dan anti-
metastasis telah dipelajari. Di samping itu, penglibatan laluan isyarat Wnt dalam 
aktiviti anti-kanser ekstrak dan pecahan kulit bawang merah juga disiasat. Ekstrak 
(E1 dan E3) dan pecahan (F1, F2, F1W dan F2W) menunjukkan kesan melarang 
daya maju sel MDA-MB-231. Walau bagaimanapun, nilai IC50 ekstrak dan pecahan 
kulit bawang merah tidak mendorong apoptosis dalam MDA-MB-231. Dalam 
analisis kitaran sel, hanya E1 dan F1 menjejaskan kitar sel MDA-MB-231 selepas 
rawatan selama 24 jam, 48 jam dan 72 jam. Di samping itu, E1, F1, F2, E3, F1W dan 
F2W menunjuk aktiviti anti-metastatik melalui perencatan aktiviti lekatan sel-
xvii 
 
fibronektin, penghijrahan sel dan pencerobohan sel. Analisis Western blotting 
menunjukkan bahawa aktiviti anti-kanser ekstrak dan pecahan kulit bawang merah 
tidak dikaitkan dengan laluan isyarat Wnt. E1 dan F1 cenderung untuk 
mempengaruhi tahap ekspresi Akt fosforilasi (Ser473) dalam MDA-MB-231. Selain 
itu, kajian tersebut juga mengesan perubahan tahap ekspresi β-catenin fosforilasi 
(Ser33) dalam MDA-MB-231 yang dirawat dengan E1 selama 24 jam. Oleh itu, 
laluan yang mungkin dicetuskan oleh E1 dalam MDA-MB-231 adalah melalui laluan 
isyarat bergantung Akt dan β-catenin, manakala F1 mungkin menunjuk anti-kanser 
aktiviti melalui Akt sahaja, seperti yang ditunjukkan dalam kajian tersebut. Tahap 
ekspresi protein β-catenin fosforilasi (Ser552) menurun dalam MDA-MB-231 yang 
dirawat dengan E1, E3, F1W dan F2W. Ini menunjukkan bahawa E3, F1W dan F2W 
juga mendorong aktiviti proliferatif dan anti-metastatik melalui laluan β-catenin. 
Sebaliknya, F2 mungkin menunjukkan aktiviti anti-kanser melalui laluan yang 
berlainan daripada laluan isyarat Wnt. Kajian ini memberi maklumat berguna tentang 
kesan anti-kanser dari ekstrak dan pecahan kulit bawang merah dalam kanser 
payudara, di mana ekstrak dan pecahan tersebut boleh menjadi ejen anti kanser yang 
berkesan untuk mengatasi rintangan terapi kanser dan untuk menghasilkan terapi 










EFFECT OF RED ONION (Allium cepa) PEEL EXTRACTS AND 
FRACTIONS ON CELL PROLIFERATIVE AND METASTATIC 
ACTIVITIES IN MDA-MB-231 
 
ABSTRACT 
Cancer is the leading cause of mortality in Malaysia and other developing 
countries. The disease causes the abnormal cells divide uncontrollably and have the 
ability to invade normal tissues. Although there are advanced cancer treatments 
being developed, the mortality rate due to cancer remains high especially in the 
patients with invasive cancers. As such, there is a need to discover more effective 
anti-cancer agents from various resources. Flavonoids, such as quercetin, are found 
in high levels in onions bulb and onion peel. Flavonoids have been demonstrated to 
induce anti-proliferative and potential anti-cancer activities. For the reason, the 
present study was conducted with the objective to study the anti-cancer property of 
red onion (Allium cepa) peel extracts and its fractions by investigating the effects in 
MDA-MB-231, MCF-7 and Cal-27. The effects of red onion peel extracts and its 
fractions in the anti-proliferative activity, induction of apoptosis - programmed cell 
death and anti-metastasis were studied. In addition, the involvement of Wnt 
signalling pathway in the anti-cancer activity of red onion peel extracts and its 
fractions was also investigated. In the results, the extracts (E1 and E3) and fractions 
(F1, F2, F1W and F2W) showed promising inhibitory effect on cell viability of 
MDA-MB-231. However, the IC50 values of the extracts and fractions did not induce 
apoptosis in MDA-MB-231. In cell cycle analysis, only E1 and F1 affected the cell 
cycle of MDA-MB-231 after 24 hours, 48 hours and 72 hours treatments. In addition, 
E1, F1, F2, E3, F1W and F2W exerted anti-metastatic activity via inhibition of cell-
xix 
 
fibronectin adhesion activity, cell migration and cell invasion. Western blotting 
analysis demonstrated that the anti-cancer activity of red onion peel extracts and its 
fractions was not associated with Wnt signalling pathway. E1 and F1 tended to affect 
the expression level of phosphorylated Akt (Ser473) in the treated cells. Moreover, 
the study also detected changes in the expression level of phosphorylated β-catenin 
(Ser33) in MDA-MB-231 treated with E1 for 24 hours. Therefore, the possible 
pathways triggered by E1 in MDA-MB-231 were likely via Akt and β-catenin 
dependent pathways, whereas F1 might exert the anti-cancer activity via inhibition of 
Akt only, as determined in this study. The protein expression level of phosphorylated 
β-catenin (Ser552) was down-regulated in E1, E3, F1W and F2W treated MDA-MB-
231, indicating that E3, F1W and F2W might also exert anti-cell proliferative and 
anti-metastatic activities via inactivation of β-catenin pathway. On the other hand, F2 
might exhibit the anti-cancer activity via different pathways, which is independent of 
Wnt signaling pathway. The study provides useful information on the anti-cancer 
effect of the red onion peel extracts and its fractions in breast cancer, where the test 
extracts and fractions may be effective anti-cancer agents for overcoming cancer 













Globally, over six million people die because of cancers. It is estimated that 
thirty million of new cancer cases will occur by 2030 (Katikireddi & Setty, 2013). 
Cancer cells are different than normal cells as abnormal cells metastasize and grow 
uncontrollably (Zhou, 2014). Cancerous cells often invade neighbouring tissues and 
develop secondary tumors at distant sites (Alabsi et al., 2012). Cancerous cells are 
proven to express the traits of sustainable proliferation, cell death resistance, 
angiogenesis, immortality, invasion and metastasis (Hanahan & Weinberg, 2011).  
 
Breast cancer-related mortality is increasing in developing countries in 
relation to the genetic factor, cultural diversity, ineffective treatments and late stage 
diagnosis (Bines & Eniu, 2008). The currently available treatments for this cancer 
are surgical, radiation and chemotherapy. On the other hand, oral cancer is the sixth 
most common cancer in the world, which accounts for up to 40% of cancer cases 
diagnosed in India and South East Asia. However, this cancer is not common in 
western countries.  
 
Natural products, such as garlic, shallot and onion, have been proven to have 
in vitro anti-cancer property via inhibiting the growth of cancer cells or induction of 
apoptosis (Azadi et al., 2008; Griffiths et al., 2002). The products usually contain 
very high natural flavonoid. Onions (Allium cepa L.) belongs to Allium plants that 
can be found worldwide (Griffiths et al., 2002). Flavonoids and alk(en)yl cysteine 
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sulphoxides (ACSOs) in onions are found to be beneficial in human health (Griffiths 
et al., 2002).  
 
The study aimed to determine the cytotoxic effect of red onion (Allium cepa) 
peels in MCF-7, MDA-MB-231 and Cal-27. Moreover, the anti-metastasis activity 
and the association of aforementioned cellular processes with Wnt signaling pathway 
triggered by the red onion peel extracts and its fractions on MDA-MB-231 were 
investigated.  
 
1.2 Problem statements 
 Cancers have claimed over millions of lives every year. It is estimated that 
approximately 1,688,780 new cancer cases happen in 2017 (American Cancer 
Society, 2017). The World Health Organization (WHO) estimated that the number of 
cancer deaths will increase to 13.1 million by 2030 (Farooqui et al., 2013). Around 
6,000,920 Americans are expected to die because of cancers (American Cancer 
Society, 2017). It is estimated that about 252,710 women and 2,470 men in the US 
will be diagnosed with breast cancer in 2017.  
 
 Currently, there is no effective treatment for human cancers with least side 
effects even though many studies have been conducted in the search for potential 
anti-cancer agents. Current cancer treatments, such as surgery, chemotherapy and 
radiotherapy, have a wide range of side effects and deficiencies (Shahneh et al., 
2013). Current cancer treatments possess adverse side effects, such as pain, vomiting, 
and weakened the immune system. Furthermore, cancer cells could develop 
resistance towards the chemotherapy. Moreover, aggressive cancers, such as triple 
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negative breast cancers (TNBC), have a poor prognosis and low survival rate. The 
long term recurrent rate of breast cancer remains high and metastatic relapse remains 
an incurable disease (Li et al., 2014). Cancer treatments have limited efficacy against 
TNBC. Moreover, the outcomes of current cancer treatments are unsatisfactory, 
particularly on the metastasis. Metastasis is the major cause of cancer deaths. 
Metastasis is the spread of cancer cells from the primary site to the distant location. It 
is a multi-step process. Cancer cells acquire cell motility, cell migration, cell 
invasion and angiogenesis during metastasis (Deep & Agarwal, 2010). Current 
cancer treatments have limited effect against metastatic cancer (Deep & Agarwal, 
2010). Thus, it is very important to find new alternative cancer treatments for 
metastasis.  
 
 Onions are one of the major vegetables consumed in Malaysia, and hence, 
onion peels are the most common waste discarded in our kitchens (Abdullah et al., 
2013). Onions are also consumed widely in other countries. More than 450,000 
tonnes of onion waste is produced in the European Union every year (Roldan et al., 
2008). It is reported that red onion contains a higher amount of total flavonoids than 
the white and yellow onions (Shon et al., 2004). In addition, the outer skin of red 
onions had higher antioxidant activity than yellow and white onions. Red onion 
contains organosulfur compounds and flavonoids, such as kaempferol, quercetin and 
anthocyanins. According to Griffiths et al. (2002), onions have anti-carcinogenic 
property, antibiotic activity, antioxidant property, lower blood cholesterol level, anti-
cancer activity and property to reduce lipid peroxidation. Red onions have a higher 
yield of phenol and total flavonoid contents than white and yellow onions (Shon et 
al., 2004). Red onion has been demonstrated to contain quercetin, anthocyanins and 
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polyphenolic compounds that display anti-cancer property. Therefore, the study was 
conducted to determine the anti-cancer activity of the red onion peel extracts and its 
fractions in human cancer cells. 
 
1.3 Significance of the study 
As the study focus on the cytotoxic activity, apoptosis-programmed cell death 
and anti-metastatic property in breast cancer cell lines, as well as the association of 
aforementioned cellular processes with Wnt signaling pathway, the outcomes of this 
study may provide a framework on the effectiveness of red onion peel extracts and 
fractions against TNBC. This study has an impact on drug discovery as it provides 
the translational potential for cancer treatment, particularly the metastatic property on 
breast cancer. Moreover, the waste of red onion could be utilized for anti-cancer 
approaches. In addition, the mechanism of the anti-cancer property of the red onion 
peel extracts and its fractions are illustrated. Furthermore, cost effective health 
supplements that complement cancer therapy could be introduced using the red onion 













The main objective of this study was to investigate the anti-cancer property of 
the red onion peel extracts and its fractions. The flow chart of the methodology is 
shown in Figure 1. 
 
To do so, four specific objectives of the project are represented as follows:  
1. To evaluate the cytotoxic effect of the red onion peel extracts and its fractions in 
human cancer cell lines using MTT assay.  
2. To investigate the programmed cell death induced by the red onion peel extracts 
and its fractions in MDA-MB-231 using DNA fragmentation assay, Cell staining 
and Flow cytometry. 
3. To determine the anti-metastatic effect of the red onion peel extracts and its 
fractions in MDA- MB-231 using Cell-fibronectin adhesion, Wound healing cell 
migration, Boyden chamber motility and Matrigel invasion assays. 
4. To study the association of aforementioned cellular processes with Wnt signaling 
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It is reported that one out of two men and one out of three women are 
diagnosed with cancers in their lifetime (Chial, 2008). This phenomenon is due to the 
close association of carcinogenesis that harboring mutations. Mutations are the 
hallmark of cancer (Loeb & Loeb, 2000). It is also one of the factors that contribute 
to the cancer formation. Mutations occur due to external factors, such as carcinogens, 
industrial chemicals and endogenous sources, including free radicals, DNA 
polymerase errors, depurination, chromosomal aberrations and others (Loeb & Loeb, 
2000).  
 
Cancer is a heterogeneous disease with deregulation of multiple cell signaling 
pathways. It is reported over hundreds of genes have been revealed to regulate 
tumour initiation and progression, where cellular transformation happens through the 
accumulation of cellular mutation and epigenetic changes (Pedraza-Farina, 2006; 
Jeggo et al., 2016). Mutations regulate the increased expression of oncogenes; the 
mutated form of normal cellular genes (proto-oncogenes) (Pedraza-Farina, 2006). 
Proto-oncogenes are a group of normal genes that could cause cancer formation 
when the genes are mutated. Oncogenes encode proteins that are usually involved in 
cell division, inhibition of cell differentiation and evasion of cell death (Chial, 2008). 
The underlying mechanism associated with mutation of proto-oncogenes are the 
point mutation, deletions or insertion, chromosomal translocation that lead to 
hyperactive gene products, increased transcription, higher gene and protein 
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expression (Chial, 2008). Activation of oncogenes stimulates the growth of cancer 
cells (Pedraza-Farina, 2006; Jeggo et al., 2016). Tumor suppressor genes, on the 
other hand, act as negative regulators of cellular growth. It is reported that mutation 
of a single oncogene or tumour suppressor gene is not sufficient to induce cancer 
formation (Pedraza-Farina, 2006). Oncogenesis could occur via single gene disorder, 
multiple genes disorder and chromosome disorder (Liu et al., 2011), where EGFR, 
PDGFR, Her2/neu, cyclin D, CDK4 and β-catenin are the examples of oncogenes, 
whereas TGF-βR, p53, bcl-2, bax, APC, PTEN are the selected examples of tumour 
suppressors (Malarkey et al., 2013).  
 
2.2 Cancer 
Cancer is one of the deadly diseases in Malaysia. In 2007, about 18,219 new 
cancer cases are registered in National Cancer Registry (Bain et al., 2014). Lung 
cancer, colorectal cancer, nasopharynx cancer, prostate cancer and lymphoma were 
the most common cancers found among Malaysian males, whereas breast cancer, 
colorectal cancer, cervix cancer, ovary cancer and lung cancer were the common 
cancers found in females (Zainal Ariffin & Nor Saleha, 2011). As a matter of fact, 
cancer is the major health concern now globally.  
 
Several important alterations occur in order for the transformation of 
cancerous cells to happen. The alternations, including increased growth signals, 
resistant towards anti-growth signals, the escape of apoptosis, angiogenesis, 
unlimited potential in replicative, invasion, metastasis and genome instability 
(Hanahan & Weinberg, 2011). Normal cells require growth signal for entering 
proliferative phase. However, cancerous cells can generate growth factors to sustain 
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the growth; therefore, it reduces their dependence on mitogenic growth signals 
(Hanahan & Weinberg, 2011). Anti-growth signals can inhibit proliferative state of 
the cells temporarily or permanently.  
 
 Cancer is a disease, in which the cells grow uncontrolled and spread as 
abnormal cells. It has been demonstrated that this disease is caused by unhealthy 
diets, infectious organisms, tobacco, inherited genetic mutations and immune 
conditions (American Cancer Society, 2016). Cancer has higher mortality rate than 
acquired immune deficiency syndrome (AIDS), tuberculosis and malaria (American 
Cancer Society, 2016). Globally, one in seven deaths is associated with cancers. In 
2012, there were 14.1 million new cancer cases diagnosed worldwide, whereby 8.2 
million cancer deaths happened worldwide; 2.9 million in developed countries and 
5.3 million in developing countries. It is expected that 21.7 million new cancer cases 
will be occurred by 2030. 
 
 The three most common cancers in economically developed countries are 
prostate cancer, lung cancer and colorectal cancer among men; and breast cancer, 
colorectal cancer and lung cancer among women (American Cancer Society, 2016). 
For economically developing countries, the three most common cancers are lung 
cancer, liver cancer and stomach cancer in male; and breast cancer, cervix uteri 
cancer and lung cancer in females. Different geographic areas cause different types 
of cancers. Breast cancer was the most common cancer diagnosed among women in 
19 out of 21 countries (American Cancer Society, 2016). Age structure of the 
population, the availability and use of diagnostic tests, and the quality of treatments 
are the factors result in geographic differences in cancer occurrence.       
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2.3 Breast cancer 
Breast cancer is the disease that formed in the tissues of the breast. Both men 
and women can be affected by this disease. In Malaysia, about 1 in 20 women are 
diagnosed with breast cancer (Musa et al., 2011). Breast cancer is the second most 
commonly diagnosed cancer in the world (Ferlay et al., 2015). Breast cancer is at the 
highest rank of women’s cancer that prone to the ratio of 1:20 in Malaysia (Yip et al., 
2006). About 1 million new cases of breast cancer are registered annually worldwide 
(McPherson et al., 2000). Breast cancer patients have better survival rate if the 
disease is detected early (Nor-Afiah et al., 2011). It was reported that breast cancer 
ranked as the fifth of the most cancer death with approximately 458,000 of deaths 
occur worldwide (Jemal et al, 2011).  
 
 In economically developed countries, the breast cancer patients tend to have 
good prognosis than the patients in developing countries (American Cancer Society, 
2016). Asian countries have the largest numbers of breast cancer incidences, with 
39% of the new cases diagnosed and 44% of cancer death. The United States and 
Canada have detected 15% of the new breast cancer cases and 9% of breast cancer 
deaths, whereas African countries account for 8% of the new breast cancer cases and 
12% of breast cancer death (American Cancer Society, 2016). 
 
 It is reported that geographic differences affect breast cancer rate. Northern 
America, Australia, and Northern and Western Europe have higher incidence rates 
than Asia and Africa. The variation might due to different lifestyles and 
environmental factors. For example, 19.3 per 100,000 women in Eastern Africa and 
89.9 per 100,000 women in Western Europe are diagnosed breast cancer (Curado, 
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2011). As for the Africa, South African Republic has the highest incidence rate of 
breast cancer, whereas Sudan and Ghana have the lowest incidence rates in Africa 
(Curado, 2011). In Asia, breast cancer incidence is lower than Western countries. 
Nevertheless, breast cancer remains a leading type of women’s cancer in Asia. 
Singapore, Japan and Hong Kong have the highest rate of breast cancer incidence 
than India, Thailand and Korea (Curada, 2011). In Japan and Hong Kong, the most 
affected women are aged 45-50 years old, while this age group of Indian women is 
less affected. There is the difference in peak age for breast cancer patients in Asian 
countries and Western countries. The peak age of breast cancer patients in Asian 
countries is between 40-50 years old, and in Western countries, the peak age is 
between 60-70 years old (Curada, 2011).  
 
The symptoms of breast cancer are skin dimpling, changes in skin colour or 
texture and the lump in the breast. The early stage of breast cancer has potential to be 
cured with 84% of five-year survival rate, while for the advanced stage of cancer, 
only 18% of five-year survival rate is predicted. Breast cancer usually develops from 
non-metastatic and hormone-dependent to highly invasive and hormone-independent 
properties.  
 
Alcohol consumption is one of the factors that increase the occurrence of 
breast cancer among women. However, a study showed consumers of wine had a 
lower risk of getting breast cancer compared to none wine drinkers as the presence of 
polyphenols particularly anthocyanins and resveratrol in wine (Delmas et al., 2006; 
Arranz et al., 2012). Resveratrol inhibits tumor growth and induces apoptosis in vitro 
(Delmas et al., 2006). Breast cancer can be categorized based on the expression of 
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receptors, such as estrogen receptor (ER), Her2 receptor and progesterone receptor 
(Pervaiz et al., 2015). These markers could be the target for cancer treatment. Her2 
belongs to type 1 receptor tyrosine kinase family and it was found that the expression 
of Her2 is upregulated by 25-30% in human breast cancer (Barros et al., 2010). 
However, no specific treatments are available for both ER- and Her2 negative tumors 
till now (Huang et al., 2013).  
 
2.4 Breast cancer risk factors 
 Breast cancer is the major public health problem among females. The risk 
factors, such as the late age of first pregnancy, lower age of menarche, obesity, 
alcohol consumption, inactivity, environmental exposure, genetic and hormone 
replacement therapy, are associated with higher breast cancer risk (Veronesi et al., 
2005; Howell et al., 2014). Generally, breast cancer risk factors could be defined as 
modifiable and non-modifiable factors. Lifestyle behaviors and exogenous hormone 
exposure are the examples of modifiable risk factors, whereas aging, family history, 
late-onset menopause and precancerous breast lesion are grouped in non-modifiable 
risk factors (Pruthi et al., 2015).   
 
 Genetic mutations, deficiency in diet and the use of oral contraceptives 
promote the chances of getting breast cancer (Veronesi et al., 2005). Furthermore, 
the risk factors of breast cancer are mostly related to estrogen exposure and age, and 
mutations in BRCA1 or BRCA2 have been observed to increase the risk of getting 
breast cancer (Bozovic-Spasojevic et al., 2012). A woman, who has no family 
history of breast cancer, is considered to have average breast cancer risk. In general, 
women have the average 12% risk of developing breast cancer in the lifetime (Pruthi 
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et al., 2015). A woman is defined to have high breast cancer risk when her first-
degree relatives are diagnosed with breast cancer before age 50 years old, or the 
women has history of atypical hyperplasia, history of lobular carcinoma in situ, 
increased mammographic breast density, 5 years Gail model risk of more than 1.7%, 
exposure to chest radiation at the age of 10 to 30 years and International Breast 
Cancer Intervention Study (IBIS) model lifetime risk of more than 20% (Pruthi et al., 
2015). A woman, who has BRCA1 or BRCA2 mutation carrier, is defined at very 
high risk of developing breast cancer (Pruthi et al., 2015). It is estimated that 40-85% 
of women at very high breast cancer risk develop breast cancer in their lifetime. 
Reduction of calories uptake, more exercises, and lower consumption of alcohol help 
in reducing breast cancer formation (Parkin et al., 2011; Hansen & Steven, 2012). 
 
2.5 Oral cancer 
Oral cancer contributes 2-4% of cancer cases in the world (Markopoulos, 
2012). Oral cancers, including cancer of tongue and mouth, are usually due to the 
uses of tobacco, alcohol and poor oral hygiene. A study showed that the risk of oral 
cancer is 100% related to tobacco and 90% related to alcohol, while 50.7% and 
59.3% are related to sun exposure and older age, respectively (Lopez-jornet et al., 
2007). Besides tobacco and alcoholic drinks, diet, infectious agents, chemical 
irritants and frank carcinogens also contribute to oral cancers (Meurman, 2010).  
 
South Asian countries have a higher rate of oral cancer because of the 
practices of bidi smoking, tobacco smoking, chewing betelquid and alcohol 
consumption (Madani et al., 2012; Zain, 2001). Bidi is the type of thin South Asian 
cigarette, which contains dried crushed tobacco flakes rolled in tendu leaves, whereas 
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betel quid is a type of tobacco that is wrapped inside a betel leave and plated on the 
side of the mouth (Madani et al., 2012). Smoking and quid chewing are carcinogenic 
because smoking and quid chewing cause oxidative stress, in which the acts damage 
DNA and lead to mutagenesis (Zain, 2001). Moreover, consumption of fast food, 
canned food, snack and fermented food increase the risk of getting oral cancer 
(Amtha et al., 2009). Fast food can cause oral cancer because of the high fat level 
content in the food. The fat contents in the fast food produce polycyclic aromatic 
hydrocarbons (PAH), which are proven to induce cancer in laboratory animals 
(Grrosvenor & Smolin, 2002). Furthermore, the fermented and canned food may 
contribute to cancer formation since these foods are associated with cancers 
especially gastric cancer (Grrosvenor & Smolin, 2002). 
 
Current treatments for oral cancers include radiotherapy, surgery, 
chemotherapy or combination of these treatments (Huang & O’Sullivan, 2013). Oral 
cancer has higher mortality compared to other cancers because most of the patients, 
who are diagnosed with advanced oral cancer, cancer recurrences and metastasis, are 











2.6 Oral squamous cell carcinoma (OSCC) 
Oral squamous cell carcinomas (OSCC) often happen in the oral cavity and it 
is normally being ignored by patients during the early stage of cancer (Huang et al., 
2014). The mortality rate of OSCC is not improved despite the advances of medical 
approaches (Markopoulos, 2012). The percentage of mortality of this disease in male 
patients is 3.1 out of 100,000 people, whereas the percentage of mortality in female 
patients is 1.4 out of 100,000 people (Mehrota & Yadav, 2006). The 5 year survival 
rate of OSCC is 40-50% (Markopoulos, 2012). Tongue, lips and floor of the mouse 
are the common sites for the development of OSCC. OSCC is difficult to be detected 
in the early stage of the disease because it is painless.  
 
2.7 Current cancer treatments 
Current anti-cancer drugs include bisphosphonates, camptothecin, topotecan, 
irinotecan and tamoxifen, which cause side effects to cancer patients namely hair loss, 
nausea, vomiting, fatigue and thinning (Jordan, 1993; Aslam et al., 2014). Tamoxifen 
is used to treat breast cancer. However, according to the study, tamoxifen causes 
liver tumors and endometrial carcinoma (Jordan, 1993). Other side effects of 
applying tamoxifen in cancer treatment are insomnia, vasomotor instability, 
headache, pain, nausea, vomiting and others (Jordan, 1993). The first line treatments 
for breast cancer that is currently practiced are surgery and radiotherapy (Liu et al., 
2009). It is then supplemented with chemotherapy. ER-positive breast cancer cells 
can be halted by anti-hormonal drugs, in which the drugs inhibit the interaction of 
oestradiol with ER (Liu et al., 2009). However, ER-negative breast cancers are more 
invasive and aggressive with poorer prognoses (Bae et al., 2015; Rochefort et al., 
2003;), which cannot be halted with anti-hormonal drugs. About 10% of breast 
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cancer incidence is also correlated to the genetic disorder, e.g. BRCA1 and BRCA2 
mutations (Lillie et al., 2007).  
 
 Chemoprevention has been demonstrated to reduce cancer invasive especially 
in high-risk populations (Bozovic-Spasojevic et al., 2012; Howell et al., 2014). 
Chemoprevention is defined as the usage of natural or pharmacologic agents in 
reducing the invasiveness of cancers (Steward & Brown, 2013). Chemoprevention 
utilizes the selective receptor modulators, such as tamoxifen, and aromatase 
inhibitors, such as anastrozole, for reduction of breast cancer risk (Pruthi et al., 2015). 
Tamoxifen, raloxifene, exemestane and anastrozole are proven to reduce breast 
cancer incidence in women at increased risk of breast cancer (Pruthi et al., 2015). 
Generally, chemoprevention can be divided into three settings; primary, secondary 
and tertiary. Primary chemoprevention prevents the onset of disease, secondary 
chemoprevention cures the affected cell population and tertiary chemoprevention 
provides protection against second primary tumors (Bozovic-Spasojevic et al., 2012). 
The ideal chemoprevention agents must have the following requirements; effective 
against cancerous cells, safe and cost saving.  
 
 The mortality rate of OSCC remains low despite improvement in therapeutic 
approaches (Markopoulos, 2012). Surgery and radiotherapy are used in the early 
stage of oral cancer, as for the third and fourth stages of OSCC, a combination of 
surgery, chemotherapy and radiotherapy is used (Markopoulos, 2012). Targeted 
molecular therapy has limited adverse effects on non-cancerous cells and this 




2.8 Cancer cells resistance to chemotherapy 
Chemotherapy removes cancer cells and reduces the growth of the cancer 
cells using drugs. However, standard chemotherapies do not inhibit the motility of 
the cancer cells (Ham et al., 2015). Chemotherapy induces programmed cell death 
and also inhibits division in cancer cells mainly (Ham et al., 2015). It is defined that 
chemotherapeutic failure was associated with genetic alteration of cancer cells and 
resistance to drug treatment (Rebucci & Michiels, 2013). Mutation in the genome of 
tumor cells and epigenetic changes contribute to the drug resistance. The resistances 
of cancer treatments do not limit to conventional chemotherapy, but also targeted 
therapies (Rebucci & Michiels, 2013). Cancer possesses thousands of mutations due 
to genome instability. A study defines six hallmarks of anti-cancer drugs resistance 
as following; alteration of drug targets, up regulation of the expression of drug 
pumps, detoxification, reduced apoptosis, alteration of cell proliferation and 
increased DNA damage repair (Cree & Charlton, 2017). 
 
Cancer cells able to alter drug’s targets through down regulation of targeted 
gene expression and activation of alternative molecular mechanisms (Cree & 
Charlton, 2017). In addition, the expression of drug efflux pumps is also important in 
developing resistance to drugs. The APT-binding cassette (ABC) superfamily of 
proteins in cancer cells protect the cells via pumping out of anti-cancer drugs (Cree 
& Charlton, 2017). MDR1 (ABCB1) gene is responsible for regulating the classical 
response to drug resistance. On the other hand, phenolic glycoprotein (PgP), a 
membrane-based xenobiotic pump molecule, able to eject drugs out from the cells, 




Expression of detoxification mechanism is one of the anti-cancer resistance 
hallmarks, whereby local drug detoxification contributes to anti-cancer resistance 
(Cree & Charlton, 2017). Reduced susceptibility to apoptosis and cell death, or 
avoidance of apoptosis also caused drug resistance (Cree & Charlton, 2017). Another 
hallmark of drugs resistance is the alteration of proliferation and increased the ability 
to DNA repair. When cancer drugs are introduced to cancer cells, many tumours are 
initially responding to the drug treatment, however, some of the cancerous cells 
might escape from death. The remaining cancerous cells populations may regrow and 
develop a resistance to cancer treatments (Cree & Charlton, 2017). Furthermore, 
cancer cells could develop also resistance to targeted therapies, but at a lower rate 
than conventional cancer drugs. For example, cancer cells compensate for EGFR 
blockade via other signaling pathways, such as amplification of MET (Cree & 
Charlton, 2017). 
  
Taken together, multidrug resistance (MDR) is a system that protects cell 
population against drugs and other compounds (Liu, 2009). Adenosine triphosphate-
binding cassette (ABC) transporter family and other transporter superfamilies (solute 
carrier transporters) play also the roles in anti-cancer drugs resistance, where ABC 
extrudes anti-cancer compounds out from cells, while solute carrier transporter 









 Camptothecin is one of the important lead compounds in cancer research 
(Chu et al., 2014). It is a plant alkaloid that derived from the bark of Camptotheca 
acuminate, exerts anti-tumor activity against different types of cancer (Wall et al., 
1996; Jones et al., 1997; Isah, 2016). Camptothecin could be also isolated from 
Nothapodytes nimmoniana, Ophirrohiza mungos and M. foetida (Premalakshmi et al., 
2012). Camptothecin affects cell viability via breaking the double stranded DNA in S 
phase collision of replication forks with the topoisomerase 1-DNA complexes (Sims 
et al., 2009; Proszek et al., 2014). Camptothecins are quinoline alkaloids 
characterized by the planar pentacyclic ring system (Venditto & Simanek, 2010). 
Camptothecins lost its anti-cancer activity when the E-ring lactone in the structure is 
removed (Venditto & Simanek, 2010). Animal studies revealed that the toxic effects 
exerted by camptothecin, including emesis, diarrhea, dehydration and death 
(Venditto & Simanek, 2010). Furthermore, camptothecin demonstrated unpredictable 
toxicity in human in clinical trials.  
 
Camptothecin is topoisomerase I inhibitor. There are two types of 
topoisomerases namely type I and type II topoisomerases. Topoisomerases induce 
transient DNA breaks via transesterification mechanism, where type I topoisomerase 
cleave and reseal one DNA strand, whereas type II topoisomerases cleave and reseal 
both DNA strands (Pommier et al., 2010; Chu et al., 2014). Topoisomerase I is a 
nuclear enzyme that releases the topological stress (Proszek et al., 2014). It is often 
overexpressed in a variety of cancers. The enzymes are critically involved in DNA 
replication and transcription (Pommier et al., 2016). It is reported that the derivatives 
of camptothecin exert anti-cancer activity in lymphoma, colorectal and gastric 
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cancers (Chu et al., 2014). Major limitations of camptothecin including poor 
solubility and inactivity at physiological conditions. Various derivatives of 
camptothecin were developed in order to tackle the stability and solubility issues of 
camptothecin. Nevertheless, only 2 derivatives are approved for clinical use; 
irinotecan and topotecan (Venditto & Simanek, 2010). Topotecan is used for ovarian, 
small cell lung and cervical cancers, whereas irinotecan is used for metastatic 
colorectal cancer (Venditto & Simanek, 2010). Camptothecin was used as positive 
control in this study as camptothecin able to exert apoptotic cell death perfectly in 
breast cancer cell lines (Makin & Dive, 2001; Zeng et al., 2012). 
 
2.10 Side effect of current cancer treatments 
 Side effects of cancer treatments range from vomiting, anxiety, pain, 
neuropsychologic impairment, hypertension and sexual dysfunction, where these side 
effects affect the quality life of cancer patients (Redd et al., 2001). Chemotherapy 
not only kills the cancer cells but it damages normal cells, as well (Aslam et al., 
2014). A total 132 cancer chemotherapy drugs have been approved by the US Food 
and Drug administration (Aslam et al., 2014). According to the study, the most 
common side effects are the weakness, fatigue, hair loss, nausea and vomiting. 
Immunotherapy has significantly prolonged the survival time of patients with renal, 
melanoma, liver and lung cancers (Kirkwood et al., 2012; Yang et al., 2016), 
although the therapy causes also the side effects, such as fevers, diarrhea colitis, 
hepatitis, depression and hormone gland disorder (Yang et al., 2016). Surgery is a 
foundation of cancer treatment. It involves the removal of the entire tumor. The side 
effects of surgery include pain, limited range of motion, infection and bleeding 




 Metastasis is the main factor that promotes the diseases, e.g. cancers to claim 
over 6 million lives every year. Metastasis is the spread of cancer cells from one 
location to other distant location. Invasive cells of cancers can spread and invade 
other organs from the primary tumor. Metastasis involves complex cascade events, 
which allows tumor cells to detach from the primary site and attach to other organs. 
Cancer cells must be able to invade through extracellular matrix in order for 
metastasis to occur (Lee et al., 2008; Martin et al., 2013). The first step of metastasis 
is the detachment of cells primary tumors, cell extracellular matrix adhesion and 
proteolytic degradation of the matrix (Sato et al., 2005; Martin et al., 2013). 
Metastasis is a crucial impediment for the successful cancer treatment; hence, 
understanding of the underlying mechanism in metastasis may lead to effective 
targeted therapy. If particular compounds have the ability to interrupt one or more of 
metastasis processes, the compounds have the potential to act as anti-metastasis 
therapy.  
 
Most of the chemotherapy drugs were discovered from the study of potential 
anti-cancer agents in plants (Chanvorachote et al., 2016). More than 600 natural 
products display anti-cancer activity (Agbarya et al., 2014). However, inhibiting the 
anti-cancer activity alone is insufficient. There is increasing evidence revealed the 
activity of natural products in inhibiting cancer metastasis. The anti-metastatic agents, 
including curcumin, imperatorin (a compound isolated from Angelica dahurica root), 
and quercetin (Jemal et al., 2011; Nam et al., 2016; Youlden et al., 2008). Curcumin 
induces anoikis in lung cancer via down-regulation of Bcl-2 (Pongrakhananon et al., 
2010), whereas imperatorin inhibits anchorage-independent growth of lung cancer 
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cells that also enhance anoikis response of lung cancer cells (Choochuay et al., 2013). 
Anoikis is a form of programmed cell death activated by the loss of cell-extracellular 
matrix that is recognised as a vital obstacle of cancer metastasis (Chanvorachote et 
al., 2016).  
 
Epithelial-mesenchymal transition (EMT) is a process associated with cancer 
metastasis, where the epithelial cells are transformed into mesenchymal cells 
(Chanvorachote et al., 2016). EMT could be identified by the changes in cell 
morphology and expression of EMT markers, such as vimentin and N-cadherin. 
EMT alters cell components, such as adhesion molecules and cytoskeleton, thus the 
cells acquire high migratory ability to facilitate cancer metastasis. It is reported that 
natural products, such as 4,5,4’-trihydroxy-3,3’-dimethoxybibenzyl, isolated from 
Dendrobium ellipsophyllum inhibit EMT by reducing the level of EMT markers; 
Vimentin and Snail (Chaotham et al., 2014). 
 
Angiogenesis is an important step in cancer metastasis, where the cancer cells 
develop new blood vessels. Natural products are also reported to act as the inhibitor 
of angiogenesis (Agbarya et al., 2014). Tumors regulate angiogenesis via secretions 
of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor 
(bFGF). The secretions of those growth factors facilitate the growth of capillary and 
aid tumor growth by supplying nutrients and oxygen (Agbarya et al., 2014). Natural 
products, such as Artemisia annua (Chinese wormwood), Viscum album (European 
mistletoe), Curcuma longa (curcumin), resveratrol and proanthocyanidin (grape seed 
extract), quercetin and Panax ginseng have been demonstrated to display anti-




Onions (Allium cepa) are found worldwide, including Europe, Asia, North 
America and Africa (Griffiths et al., 2002; Kwak et al., 2016). Onions are widely 
used as food and supplements to treat various diseases since ancient times (Lanzotti, 
2006) because flavonoids and alk(en)yl cysteine sulphoxides (ACSOs) in onions are 
good for human health (Griffiths et al., 2002; Kwak et al., 2016).  
 
 Anthocyanins and flavanols can also be found in onions (Griffiths et al., 
2002; Kwak et al., 2016). According to Griffiths et al. (2002), onions have proven to 
exert anti-carcinogenic property, antibiotic activity, antioxidant property and anti-
cancer activity. Flavonols in onion skin play important role in giving yellow, brown 
or red colour to the skin of the onion. Red onion contains a higher amount of 
anthocyanin and quercetin in the outer peel of onion (Griffiths et al., 2002). The 
outer skin of red onions had higher antioxidant activity than the skin of yellow 
onions and white onions. Similarly, red onion has higher phenol and total flavonoids 
contents than white and yellow onions (Shon et al., 2004). Organosulfur compounds, 
such as diallyl sulphide in onions, contribute to anti-cancer property (Lai et al., 2013). 
It has been proven that flavonoids reduce free radicals or reactive oxygen species 
(ROS) produces in the biological system in the human body and also from external 
sources, such as smoking, radiations and pesticides that induce the development of 







2.13 Red onion 
 Onion is consumed raw or cooked in our daily diet. Thiol compounds in 
onion play an inhibitory role of polyphenol oxidase (PPO) activity (Kim et al., 2005). 
Allium species are also shown to exert anti-bacterial, anti-fungal and antioxidant 
activities (Benkeblia, 2005). Approximately more than 500,000 tonnes of onion 
waste is discarded in the European Union (Waldron, 2001). The onion waste 
comprises of onion skin, roots and damaged bulbs (Benitez et al, 2011). The waste 
can be used for food ingredient and other applications as onions are potential in anti-
cancer agents, antibiotics and anti-asthmatic (Moreno et al., 2006).  
 
Two major subgroups of flavonoids; anthocyanins and quercetin can be found 
in onion. It is reported that different parts of onion contain the different type of 
quercetin. Quercetin 4’-glucoside and quercetin 3, 4’-diglucoside are mainly found in 
the flesh of onion, whereas quercetin aglycon is presented in higher concentration in 
onion skin (Downes et al., 2009; Downes et al., 2010). Quercetin is proven to act as 
antioxidant agent (Bonaccorsi et al., 2008). Moreover, alk(en)yl cysteine sulphoxides 
(ACSOs) in onion are also important in the health benefiting activity of onion 
(Benitez et al., 2011).  
 
 Allium sulphur compounds play a role in regulating antioxidant and apoptotic 
activities (Rose et al., 2005). According to Stajner et al. (2006), Allium species has 
health benefiting activity against tumor promotion and cardiovascular disease. 
Onions especially red onions have better radical scavenging activities than garlic. 
Onions exhibit various bioactive activities, such as anti-bacterial and anti-fungal 
(Skerget et al., 2009). It is proven that onion skin has a higher level of flavonoids 
